pqq cofactor has been researched along with alpha-synuclein in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, S; Ikebukuro, K; Kim, J; Kobayashi, M; Kobayashi, N; Nakamura, C; Sode, K | 1 |
| Asano, R; Iguchi, T; Ikebukuro, K; Kaku, T; Kim, J; Kobayashi, M; Kobayashi, N; Nagasawa, K; Sode, K; Tsukakoshi, K; Yoshida, W | 1 |
| Kerman, K; Li, S; Noroozifar, M; Zhou, J | 1 |
| Kerman, K; Li, S; Noroozifar, M; Raja, A | 1 |
4 other study(ies) available for pqq cofactor and alpha-synuclein
| Article | Year |
|---|---|
Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.
Topics: alpha-Synuclein; Amyloid; Microscopy, Atomic Force; Molecular Structure; PQQ Cofactor; Protein Binding; Spectrum Analysis | 2006 |
Esterification of PQQ Enhances Blood-Brain Barrier Permeability and Inhibitory Activity against Amyloidogenic Protein Fibril Formation.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Peptides; Amyloidogenic Proteins; Animals; Blood-Brain Barrier; Cell Line, Tumor; Cell Survival; Esterification; Esters; Humans; Mice; Neurons; Peptide Fragments; Permeability; PQQ Cofactor; Prion Proteins; Protein Aggregation, Pathological | 2018 |
Electrochemical flow injection analysis of the interaction between pyrroloquinoline quinone (PQQ) and α-synuclein peptides related to Parkinson's disease.
Topics: alpha-Synuclein; Flow Injection Analysis; Humans; Parkinson Disease; Peptides; PQQ Cofactor | 2021 |
Understanding the Inhibitory and Antioxidant Effects of Pyrroloquinoline Quinone (PQQ) on Copper(II)-Induced α-Synuclein-119 Aggregation.
Topics: alpha-Synuclein; Antioxidants; Copper; Dopaminergic Neurons; Humans; Parkinson Disease; PQQ Cofactor; Reactive Oxygen Species | 2022 |